Trulieve Projects $225M+ Operating Cash Flow for 2026, Boosts Capex to $95M

What Happened Trulieve Cannabis Corp., one of the largest multi-state cannabis operators in the U.S., says it expects to generate at least $225 million in operating cash flow in 2026. Alongside that projection, the company raised its capital expenditure outlook to $95 million, up from prior guidance, signaling it's putting real money behind expansion plans rather than just talking growth.

Why It's Raising Capex When a company boosts its capex outlook, it usually means one of two things: it's building out infrastructure to capture more market share, or it's investing in efficiency to protect margins as competition heats up. For Trulieve, which operates cultivation facilities, processing labs, and retail dispensaries across multiple states, higher capex likely points to expanded cultivation capacity, new store openings, or upgraded processing tech ahead of anticipated demand growth.

The Bigger Cannabis Picture Trulieve's confidence in generating $225 million-plus in operating cash flow next year is notable in an industry still wrestling with federal tax burdens under IRS Code 280E, banking restrictions, and state-by-state regulatory patchwork. Strong projected cash flow suggests the company believes its core markets — likely including Florida, Pennsylvania, and Arizona — are stabilizing or growing, giving it room to reinvest rather than just cover operating costs.

What Investors and Industry Watchers Should Know Cannabis multi-state operators (MSOs) have spent the last few years focused on survival: cutting costs, refinancing debt, and waiting for potential federal rescheduling or banking reform. A raised capex outlook paired with strong cash flow guidance is a sign that at least some players in the space are shifting from defense to offense. If Trulieve executes on this plan, it could set a benchmark for how other MSOs approach 2026 budgeting.

What to Watch Next Keep an eye on where that $95 million in capex actually goes — new dispensary openings, cultivation expansion, or wholesale/processing upgrades will tell a different growth story. Also watch how Trulieve's guidance compares to peers like Curaleaf, Green Thumb Industries, and Verano as they release their own 2026 outlooks. If the sector broadly raises spending plans, it could reflect growing optimism around potential federal cannabis policy shifts, including movement on rescheduling that's been rumored for months.